[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2027550A6 - Procedimiento para preparar derivados de glicerol. - Google Patents

Procedimiento para preparar derivados de glicerol.

Info

Publication number
ES2027550A6
ES2027550A6 ES9003271A ES9003271A ES2027550A6 ES 2027550 A6 ES2027550 A6 ES 2027550A6 ES 9003271 A ES9003271 A ES 9003271A ES 9003271 A ES9003271 A ES 9003271A ES 2027550 A6 ES2027550 A6 ES 2027550A6
Authority
ES
Spain
Prior art keywords
alkyl
procedure
glycerol derivatives
rsi1
excess
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES9003271A
Other languages
English (en)
Inventor
Pierre Braquet
Colette Broquet
Paola Principe-Nicolas
Benedicte Vandamme
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898929074A external-priority patent/GB8929074D0/en
Priority claimed from GB898929075A external-priority patent/GB8929075D0/en
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Publication of ES2027550A6 publication Critical patent/ES2027550A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/10—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with one amino group and at least two hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20—Quaternary compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Furan Compounds (AREA)
  • Steroid Compounds (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR DERIVADOS DE GLICEROL DE FORMULAS GENERALES (IA), (IB) Y (IC) DONDE RSI1 REPRESENTA HIDROGENO O ALQUILO INFERIOR; RSI2 REPRESENTA ALQUILO DE 10 A 24 CARBONOS; RSI3 REPRESENTA ARILO O ALQUILO CONH-ALQUILO O CON-DIALQUILO; A REPRESENTA ****FORMULA SIN HACER**** Y REPRESENTA AMONIOS CUATERNARIOS O UN HETEROCICLO CON UN ATOMO DE NITROGENO. COMPRENDE HACER REACCIONAR COMPUESTOS DE FORMULAS (IIA), (IIB) Y (IIC) CON UN EXCESO ESTEQUIOMETRICO DE UN COMPUESTO SELECCIONADO ENTRE Y CON UN EXCESO ESTEQUIOMETRICO DE UN COMPUESTO Z, SELECCIONADO ENTRE AMINAS RELACIONADAS CON LOS AMONIOS CUATERNARIOS DEFINIDOS PARA Y; Y, PARA OBTENER COMPUESTOS (IB) O (IC), DONDE RSI1 REPRESENTA HIDROGENO, HIDROGENOLIZAR POSTERIORMENTE EL GRUPO PROTECTOR -SOSI2CHSI2O. LOS COMPUESTOS OBTENIDOS TIENEN ACTIVIDAD ANTITUMORAL.
ES9003271A 1989-12-22 1990-12-21 Procedimiento para preparar derivados de glicerol. Expired - Lifetime ES2027550A6 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898929074A GB8929074D0 (en) 1989-12-22 1989-12-22 Glycerol derivatives
GB898929075A GB8929075D0 (en) 1989-12-22 1989-12-22 Glycerol derivatives

Publications (1)

Publication Number Publication Date
ES2027550A6 true ES2027550A6 (es) 1992-06-01

Family

ID=26296423

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9003271A Expired - Lifetime ES2027550A6 (es) 1989-12-22 1990-12-21 Procedimiento para preparar derivados de glicerol.

Country Status (26)

Country Link
US (1) US5116992A (es)
JP (1) JP2648730B2 (es)
KR (1) KR950012533B1 (es)
AR (1) AR247875A1 (es)
AT (1) AT398423B (es)
AU (1) AU635991B2 (es)
BE (1) BE1004091A3 (es)
CA (1) CA2032254C (es)
CH (1) CH681225A5 (es)
DE (1) DE4041449A1 (es)
DK (1) DK171021B1 (es)
ES (1) ES2027550A6 (es)
FI (1) FI906203A (es)
FR (2) FR2656308B1 (es)
GR (1) GR1000688B (es)
HK (1) HK117993A (es)
IE (1) IE65821B1 (es)
IT (1) IT1243413B (es)
LU (1) LU87860A1 (es)
NL (1) NL9002742A (es)
NO (1) NO178698C (es)
NZ (1) NZ236483A (es)
OA (1) OA09336A (es)
PT (1) PT96322B (es)
SE (1) SE501393C2 (es)
TN (1) TNSN90153A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8928580D0 (en) * 1989-12-19 1990-02-21 Scras 3-(n-methyl-n-alkylamino)-methoxymethyl-propanol phosphocholine derivatives
US5206027A (en) * 1990-09-13 1993-04-27 Fuji Photo Film Co., Ltd. Amphipathic compound and liposome comprising the same
DE69535758D1 (de) 1994-08-29 2008-07-03 Univ Wake Forest Lipid-analoge zur behandlung von viralen infektionen
US7135584B2 (en) * 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
US5707978A (en) * 1994-11-22 1998-01-13 Clarion Pharmaceuticals Inc. Heteroaryl-substituted deoxy glycero-phosphoethanolamines
US5703062A (en) * 1995-12-07 1997-12-30 Clarion Pharmaceuticals Inc. N-het-substituted glycerophosphoethanolamines
US5730157A (en) * 1995-12-07 1998-03-24 Clarion Pharmaceuticals Inc. Method for treating viral infection
US5665714A (en) * 1995-12-07 1997-09-09 Clarion Pharmaceuticals Inc. N-substituted glycerophosphoethanolamines
US5827836A (en) * 1996-11-15 1998-10-27 Clarion Pharmaceuticals Inc. Retinoid glycerol phospholipid conjugates
US5891881A (en) * 1997-11-21 1999-04-06 Clarion Pharmaceuticals Inc. Aminoheterocycle-substituted glycerols
US20050187192A1 (en) * 2004-02-20 2005-08-25 Kucera Pharmaceutical Company Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses
PT2574341T (pt) 2004-03-29 2017-07-03 Univ South Florida Tratamento eficaz de tumores e cancro com triciribina e compostos relacionados

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2820893C2 (de) * 1978-05-12 1986-02-20 A. Nattermann & Cie GmbH, 5000 Köln Strukturanaloga von natürlichen Phospholipiden und Verfahren zur Herstellung dieser Verbindungen
US4562179A (en) * 1982-04-19 1985-12-31 Fujisawa Pharmaceutical Co., Ltd. Phospholipid derivatives, and pharmaceutical composition of the same
DE3323871A1 (de) * 1983-07-02 1985-01-03 A. Nattermann & Cie GmbH, 5000 Köln Neue 1-o-alkyl-3-amino-propan-1,2-diol-2-o-phospholipide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4863941A (en) * 1985-06-18 1989-09-05 Hoffmann-La Roche Inc. Glycerol derivatives

Also Published As

Publication number Publication date
FR2656308A1 (fr) 1991-06-28
FI906203A (fi) 1991-06-23
NZ236483A (en) 1993-02-25
ATA260590A (de) 1994-04-15
AT398423B (de) 1994-12-27
NO178698C (no) 1996-05-15
DK171021B1 (da) 1996-04-22
IT9022439A1 (it) 1992-06-19
IT1243413B (it) 1994-06-10
FR2656221A1 (fr) 1991-06-28
SE501393C2 (sv) 1995-02-06
AR247875A1 (es) 1995-04-28
PT96322A (pt) 1991-09-30
AU6837990A (en) 1991-07-11
CA2032254C (en) 1996-12-10
GR1000688B (el) 1992-10-08
FI906203A0 (fi) 1990-12-17
KR910011760A (ko) 1991-08-07
SE9003973D0 (sv) 1990-12-12
JPH0616605A (ja) 1994-01-25
HK117993A (en) 1993-11-12
TNSN90153A1 (fr) 1991-03-05
GR900100847A (en) 1992-05-12
IE65821B1 (en) 1995-11-15
IE904618A1 (en) 1991-07-17
NO905377D0 (no) 1990-12-12
OA09336A (fr) 1992-09-15
CA2032254A1 (en) 1991-06-23
JP2648730B2 (ja) 1997-09-03
LU87860A1 (fr) 1991-05-07
DE4041449A1 (de) 1991-06-27
PT96322B (pt) 1998-06-30
NL9002742A (nl) 1991-07-16
AU635991B2 (en) 1993-04-08
FR2656308B1 (fr) 1994-04-01
IT9022439A0 (it) 1990-12-19
KR950012533B1 (ko) 1995-10-18
DK304090A (da) 1991-06-23
NO905377L (no) 1991-06-24
CH681225A5 (es) 1993-02-15
FR2656221B1 (fr) 1992-09-18
BE1004091A3 (fr) 1992-09-22
US5116992A (en) 1992-05-26
SE9003973L (sv) 1991-06-23
NO178698B (no) 1996-02-05
DK304090D0 (da) 1990-12-21

Similar Documents

Publication Publication Date Title
ES2027550A6 (es) Procedimiento para preparar derivados de glicerol.
DK34793A (da) Vandoploeseligt, farmaceutisk acceptabelt salt af et monoacylderivat af rapamycin, fremgangsmaade til dets fremstilling og injicerbart, farmaceutisk praeparat indeholdende det
NO163819C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1h-imidazo(4,5-c)kinolin og derivater derav.
ES8507111A1 (es) Un procedimiento para la preparacion de compuestos de 1,4-dihidropiridina.
AR246962A1 (es) Procedimiento para preparar derivados alquilamino-alquilenicos de ciertos 2h-1-benzopiranos.
DK457286A (da) Fluorenforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
KR950011420A (ko) 트리아진 유도체, 그의 제조 방법 및 용도
JPS6440461A (en) Tetrahydroisoquinoline-2-yl derivative
ES454824A1 (es) Procedimiento para la preparacion de derivados de imidazo (1,2-a) piridina.
SE7714407L (sv) Imidazoliner och forfarande for framstellning av dem
ES8602724A1 (es) Un procedimiento para la preparacion de nuevos derivados de aminoalcoholes.
ES520868A0 (es) Un procedimiento para preparar guanidino-fenilamidinas heterociclicas sustituidas.
DK560681A (da) Alfa-azolylglycoler og fremgangsmaade til fremstilling heraf
ES475596A1 (es) Procedimiento para la preparacion de derivados de fenoxial- canolaminas
DK48188A (da) Ergolinyl-heterocycliske forbindelser og fremgangsmaade til fremstilling deraf
ES8702424A1 (es) Un procedimiento para la preparacion de tiazol y tiazin-ben-cimidazoles
SE8205533D0 (sv) Forfarande for framstellning av aminoalkylfuranderivat med terapeutisk verkan
ES369751A1 (es) Procedimiento para la preparacion de nuevos derivados de indol.
ES460786A1 (es) Procedimiento para preparar un colorante de antraquinona so-luble en agua.
ES321198A1 (es) Procedimiento para la preparaciën de derivados del aldehido salicilico de efecto fungicida
ES406768A1 (es) Procedimiento para la preparacion de nuevos derivados de indol.
ES396174A1 (es) Procedimiento para la preparacion de compuestos derivados de aminoetanol.
MX3056E (es) Procedimiento para la preparacion de derivados de alanina n , n - di sustituidos
GB1032377A (en) Asymmetrical pyridoxolyl disulphides and their preparation
ES356320A1 (es) Procedimiento para preparar agentes herbicidas.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010301